Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
about
sameAs
The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglyceridesEffects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceAPOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT studyAPOAV (T-1131>C) variant has no effect on mother's height in a large population studyGenetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancyApolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsThe human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response elementThe APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in SingaporeApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementApolipoprotein A5 and triglyceridemia. Focus on the effects of the common variantsThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchInfluence of apolipoprotein A-V on the metabolic fate of triacylglycerolA single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou ChineseAPOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levelsEffects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysisIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE studyGenetic polymorphism of apolipoprotein A5 gene and susceptibility to type 2 diabetes mellitus: a meta-analysis of 15,137 subjectsGenetic Variants Associated with Gestational Hypertriglyceridemia and PancreatitisThyroid hormone regulates the hypotriglyceridemic gene APOA5Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alphaFine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci.Loss-of-function mutations in APOC3, triglycerides, and coronary diseaseCandidate gene association resource (CARe): design, methods, and proof of conceptJoint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia.Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation.Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-studyAnalysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study.Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin.Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.INSIG1 influences obesity-related hypertriglyceridemia in humans.Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.Proteomic analysis of plasma proteins in diabetic rats by 2D electrophoresis and MALDI-TOF-MS.Atherogenic dyslipidemia: cardiovascular risk and dietary interventionRat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet.GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
P2860
Q21261422-2557BD8D-2BF4-4297-89E1-C0F711198DF9Q24302828-0F5CA529-B2A8-4584-A3CE-EFF336A044BCQ24305221-B8DBE8AD-F0D4-44E9-AA28-F97C46A68C14Q24794937-7568D800-093F-4B11-A308-9D8E474C6695Q24797224-C1B2FF5B-C81E-478C-95D7-9E35C64EA213Q26775009-746AA6DB-B126-4473-BE7D-00671370B531Q28183207-0506E420-7509-4900-A15B-A1CED58165E6Q28199120-97A280DA-F7D7-4872-A8B3-DDEC35653F72Q28204618-623A2EA4-857A-4E73-9B48-BD9C7120DE3BQ28256394-076D7A8F-B79F-404B-AA0E-CD547881FF60Q28273374-C4A49E82-B7B4-495B-9E4B-CB79627D3B6EQ28275573-4A66BB61-BD7E-47B8-B856-E102E5DD8C5AQ28281468-94A42DF3-5DCC-4482-BB7D-F21749BAFC0DQ28286033-D64F4FA6-0992-4256-A62B-AFC86DB902A2Q28286099-FECE3704-FD6E-4A30-8E30-3D46FEC3BD9FQ28286797-623D0EEC-E76C-4397-8A90-3127714B59DBQ28294769-539E2FBA-38DB-46F0-899D-76713CB3C667Q28306572-90DC5BF6-E9BF-464C-B5F5-713FC1A76476Q28308177-E855B443-E4C9-4036-91B4-590DE5352980Q28548394-E8D8A6CF-F8F8-4994-9599-1EAABAEF88D3Q28569807-5EFB2596-34F6-4971-A03A-5EB53CAEF9E6Q28584176-79FE1A67-557C-4C32-8906-FB9976DC20CAQ30252583-1D48D8EB-76A7-483C-8926-43294580D464Q30408720-B981AA3E-9A70-4669-B256-DD1A8A5289DBQ30432077-C267257C-DDFE-4599-AEC1-B69BD673D326Q30700100-1E8FE64E-FB2A-4F35-8289-ED3E7F430391Q33293923-CCE8719C-1A6B-4FDA-9E64-17496A2FF74AQ33559552-1BCF7E31-9EE6-4097-8D29-15BAC6715F92Q33568117-3B5B7E9E-297D-4267-A9B7-4198DF188966Q33613799-6193A2E0-1FD4-424D-9CAC-54273180B4E6Q33620859-F1BB07A6-5229-4F49-8874-2708C98857E9Q33653008-59003AD3-2562-46D9-A7FB-DF13EEB7F886Q33728329-C7751B53-6CD7-40A1-9CEE-272904AB12F0Q33851689-05E28DC8-F6F6-4DAA-A67A-D832313B43EDQ33923844-C0AFB8B0-9B0C-4B2E-B7C5-821FFC815692Q34048473-AF704F17-F57D-4B9B-916B-2701AB541FA8Q34132805-0C1ABD20-7EDD-4E5C-87E1-18D224372ED8Q34180234-64C9889D-56B4-4946-B9B4-6665DD019995Q34206069-D2211B1E-C641-4796-91BA-669FF3F368C1Q34208235-5A7B54B9-AAB9-4D0F-8978-FC2237DC92DB
P2860
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@ast
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@en
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@nl
type
label
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@ast
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@en
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@nl
prefLabel
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@ast
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@en
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@nl
P2093
P3181
P356
P1476
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
@en
P2093
Jaroslav A Hubacek
Jonathan C Cohen
Len A Pennacchio
Michael Olivier
Ronald M Krauss
P304
P3181
P356
10.1093/HMG/11.24.3031
P407
P577
2002-11-15T00:00:00Z